ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

E-ISSN： 1875-533x|21|28|3261-3270

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.28, 2014-09, pp. : 3261-3270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Current Medicinal Chemistry, Vol. 16, Iss. 9, 2009-03 ,pp. : 1115-1121

Bentham Science Publishers

Access to resources Recommend Favorite

Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

By Sheldon Julie Barreiro Pablo Vincent Vincent

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1171-1181

Informa Healthcare

Access to resources Recommend Favorite

MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection

By Gentile Ivan Buonomo Antonio Riccardo Borgia Federico Zappulo Emanuela Castaldo Giuseppe Borgia Guglielmo

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 719-728

Informa Healthcare

Access to resources Recommend Favorite

NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection

By Herbst D Alan Reddy K Rajender

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1337-1346

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite